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Concentrations ofambient PM2.5 (particulate matter c2.5 pm in aerodynamic diameter) were
associated with increased mortality in two prospective cohort studies. In this paper, 1 assess
whethertheweight oftheevidence supports acausal association. I assumedthe studypopulation
ineachcityto havethe sameexposure; therefore, these areecologic studies because exposure is at
the group level. Health outcome and confounding data arc at the individual level. Ambient PM
concentrations are inadequate surrogates forpersonalexposuebecausetheyare atthegroup lev
andcomprise onlyasmallproportionofpersonal xposre, theychange overtime, andtheycon-
stitute only asmallproportion ofalif span. Thestrength ofassociation and eposure-response
relationships cannot be deter ed because the ecologic group-level risk ofPM2.5 are overesti-
mated 150- to 300-fold based on an analogywith individual-levd exposure to inhaled cigarette
smoke. Risk estimates may also be high because ofconfounding from factors such as physical
activity and lung function. The evidence is not coherent because the stroger asocations are
expected to bewithmorbidity, butinstead arewithmortality. Forexmple,PM,,wa ted
with mortality but not with measurable reductions in lung function. Biological plausibility is
lacking because lifetime exposure ofrats to combustion products at concentrations two to hee
orders of tude higher than air poliution levels cause lung overloading but no consistent
reduction insurvival. Criteriaforquantitative riskassessment arenotmetsothedataare notuse-
fil forsetting air quality standards. Theweight ofevidence suggt there is no substantive basis
for concluding that a cause-effect relationship exists between long-term ambient PM2.5 and
increased mortality. Keywork airpollution, causality, confound ecologial llay, ecological
studies, epidemiology, particulate matter, prospective cohort, smoking, statistical association.
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In 1997, President Clinton approved an
EPA recommendation for a fine particulate
matter (PM2 5) National Ambient Air
Quality Standard (NAAQS) of 15 pg/m3.
Particulate matter less than 2.5 pm in aero-
dynamic diameter has heretofore been regu-
lated indirectly through regulation ofPM1O.
Fine particulates are generally derived from
high temperature processes such as combus-
tion or metallurgical operations emitting
vapors, which tend to condense on fine par-
ticulate. Tobacco smoke and atmospheric
transformation products ofSO2, NO2, and
organics (including biogenic organics) are
also mostly in the 0.1-1.0 pm aerodynamic
diameter range. The chemical composition
tends to be sulfates, acids, metal salts, and
carbon. The coarse mode is generally derived
from resuspension of soil, industrial dusts,
construction, coal and oil combustion, and
ocean spray. Composition tends to be flyash
(coal and oil), metal oxides, CaCO3, NaCl
(sea salt), pollen, mold spores, and plant
parts (1). The new standard for PM25 was
recommended because ofthe hypothesis that
fine particles "are a better surrogate for those
particle components linked to mortality and
morbidity effects at levels below the current
[PM10] standards" (2).
To establish the annual PM2.5
NAAQS, the EPA placed great emphasis
on two prospective cohort mortality stud-
ies: the Six Cities cohort (3) and the
American Cancer Society (ACS) cohort
(4). The Six Cities cohort is composed ofa
random sample of 8,111 white subjects
25-74 years of age at time of enrollment
living in six U.S. cities (Steubenville, OH;
St. Louis, MO; Portage, WI; Topeka, KS;
Waterton, MA; and Kingston/Harriman,
TN). Area PM25 air samples were collect-
ed daily from 1979 to 1985, with the
mean annual average used as the PM2.5
exposure metric. Mortality follow-up was
14-16 years, with a total of 1,430 deaths.
The ACS cohort consisted of295,223 per-
sons recruited byACS volunteers in the fall
of 1982. Vital status follow-up was for 7
years, with a total of 20,765 deaths. Area
PM2.5 samples in 50 metropolitan areas
were collected from 1979 to 1983.
Study results are presented as the risk
of mortality (e.g., total, cardiopulmonary)
associated with the difference in PM2.5
annual concentration between the highest
and lowest polluted cities. For example, in
the Six Cities study, a 26% increased risk of
mortality [relative risk (RR) = 1.26) is asso-
ciated with an exposure difference of 18.6
pg/m3 PM2.5 (the difference in annual
PM2.5 between Steubenville, OH and
Portage, WI). The results from these two
cohorts are summarized in Table 1.
A third cohort study, largely ignored by
regulators, consisted of nearly 4,000 non-
smoking Seventh Day Adventists (SDA). In
this study, similar in design to the Six Cities
and ACS cohort studies, there did not
appear to be an association between PM2,5
and mortality. Practically no mortalityresults
were reported from this study, but there was
extensive reporting onmorbidity(5,6).
The purpose of this review is to assess
whether the weight ofthe evidence supports
a causal association between chronic expo-
sure to fine particulate air pollution (PM25)
and mortality. It is important to understand
that the study of air pollution by observa-
tional studies is very difficult for a number
ofreasons, such as the complexity ofthe air
mixture, the highly correlated nature ofthe
pollutants, the relatively low exposure range
andweakstrength ofassociation in the pres-
ence ofstronger risk factors, the inability to
completely control for confounders, and the
lack ofindividual-level exposure data. These
considerations suggest epidemiology may be
at its limits (7), and it may not be possible
to correctly estimate the long-term risk of
mortality from PM air pollution from epi-
demiologystudies such as these.
Critique of Studies
The prospective cohort study (as used in
the studies reviewed here) is a mixed design
incorporating both individual-level data
(such as cause of death, age, sex, smoking
habits, body mass index, education) and
group-level data on ambient air pollution
concentrations. Variables that describe
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Table 1. Summary ofPM2.5 resultsfromthe SixCities(3) andthe American Cancer Society(4) cohortstudies
A PM2.5
(mostvs. least
Adjusted mortality risk ratios
(95% confidence intervals)
Cohort Deaths (n) polluted city) All causes Cardiopulmonary Lung cancer
Six Cities 1,430 18.6 pg/m3 1.26(1.08-1.47) 1.37 (1.11-1.68) 1.37 (0.81-2.31)
ACS 20,765 24.5 pg/M3 1.17 (1.09-1.26) 1.31 (1.17-1.46) 1.03 (0.80-1.33)
groups of individuals are called ecological,
or group-level data. These studies analyze
group-level data because there are no indi-
vidual-level exposure data to any air pollu-
tant for any ofthe subjects in these studies.
Conceptually, analysis of the data was
conducted as ifthe two studies were experi-
mental studies. In brief, differences in mor-
tality (or survival) between groups (Six
Cities, 50 metropolitan areas) were regressed
against differences in annual PM25 while
adjusting for differences in risk factors such
as age, smoking, body mass index, and edu-
cation. However, these are observational
studies, not experimental studies. Cohort
members were not randomly assigned in
each city, and it is impossible to achieve
between-city similarity in all-important risk
factors. There is also not enough informa-
tion available on each individual to make
adequate statistical adjustments for differ-
ences in some risk factors. Thus, it may not
be possible to reliably estimate the risk asso-
ciated with between-city differences in
PM2.5.
These PM25 cohort studies have gener-
ated the hypothesis that long-term exposure
to annual PM25 concentrations at or above
about 15 pg/--3 increases total and car-
diopulmonary mortality. This hypothesis
will be evaluated to determine if it is sup-
ported by the evidence, and whether the
associations observed are likely to be causal.
This discussion of the scientific evi-
dence will follow a simplified approach
that is the logical progression from hypoth-
esis to risk assessment: generate hypothesis
-e test hypothesis and demonstrate
cause-effect -> risk assessment.
Testing the hypothesis and establishing
causality is a process of developing and
assessing the body of data from individual-
level epidemiology and experimental studies.
Each study must be evaluated regarding its
suitability; for example, are individual-level
data available for both exposure and
response, and is there a lack ofsignificant
bias such as from confounding? The suitabil-
ityofthe individual studies will be integrated
into the discussion ofcriteria propounded by
Hill (8) for determining whether an associa-
tion is causal ormerelystatistical.
The questions ofsuitabilityoftheindivid-
ual studies and assessment ofa causal versus a
statistical association arediscussedbelow.
The section on risk assessment will con-
clude with a discussion of suggested
requirements for epidemiological studies in
estimating risk and in developing air quali-
ty standards.
Ecologic Study Design
As mentioned above, the prospective
cohort study design incorporates individ-
ual-level data on cause of death, potential
confounders (such as for age, sex, smoking
habits, body mass index, education), and
group-level (ecological) data on exposure
(sulfate and PM,25 in the ACS cohort;
total, inhalable and fine PM, sulfates, acidi-
ty, SO2, NO2, and 03 in the Six City
cohort). The ecological study design is suit-
able for generating a hypothesis, but is gen-
erally not suitable for testing a hypothesis.
Weaknesses in the study design and the
need for independent confirmation using
individual-level data are two reasons that
caution in interpretation of ecologic study
results is needed.
Weakness ofEcologic StudyDesign
Ecologic studies are generally considered
inferior to individual-level studies because
1) they are subject to biases not present in
individual-level studies; 2) the biases in
ecologic studies are less well understood;
and 3) the effect ofbiases on risk estimates
is unpredictable in ecologic studies.
For example, Brenner et al. (9) showed
that while exposure misclassification in
individual-level studies often biases the risk
estimate toward the null, exposure misclas-
sification in ecological studies may produce
extreme overestimates of risk [see also
Greenland (10)]. The "ecological fallacy"
problem is one of falsely inferring that
associations based on group data apply to
individuals. That is, there is no way to
know if the cohort members who died are
also the same individuals who had high
exposure to PM2 relative to those who
did not die. The 1ack of any information
on individual-level exposure has led some
epidemiologists to conclude that one is
"never justified in interpreting the results
of ecological analyses in terms of the indi-
viduals who give rise to the data" (11).
Temporality. The only causal criterion
that must be met is that exposure must pre-
cede disease. For chronic disease with long
latent periods, exposure must occur years or
decades before disease. In these studies it is
clear that exposure to ambientPM2.5 began
at birth, so PM25 exposure clearly preceded
disease. However, the estimates ofexposure
meet neither of the temporal criteria for
latency or precedence. In the Six Cities
study, deaths were tabulated for the periods
between about 1979 and 1991, and PM2.5
data were collected beginning in the late
1970s. For the ACS cohort, vital status was
assessed between 1982 and 1989, and fine
particulate datawere collected from 1979 to
1983. Thus, the exposure in the Six City
study was concurrent with the responses. In
theACS cohort, therewas inadequate laten-
cy because the exposure estimates were col-
lected for no more than 3 years before the
response for chronic diseases, which takes
decades to develop. In both cases, the tem-
poralitycriterion was not met.
One could argue that estimated expo-
sure is a surrogate for lifetime exposure and
therefore the temporality criterion is met.
The following discussion suggests that
ambient concentration as used in these
studies is not an adequate surrogate for life-
time exposure.
Exposure = Concentration x Time. In
both the Six Cities andACS cohorts, statis-
tically significant associations were reported
between mortality (total and cardiopul-
monary) and mean ambientPM2.5 concen-
trations and over the concentration range
equivalent to the difference between high
and low polluted cities. Ideally, one would
like to either measure or estimate long-
term personal exposure to different air pol-
lutants, i.e., collect individual-level data
(12). Measurement ofpersonal exposure as
a maximum involves wearing a personal
monitor for many years. Estimation of
individual-level exposure as a minimum
might mean keeping a time-activity diary.
What has been used in these studies as a
surrogate for exposure is ambient mean
concentrations of the geographical areas of
the studysubjects.
The use ofmean ambient air concentra-
tion to estimate cumulative long-term expo-
sures in the Six Cities and ACS cohorts is
adequate onlyifseveral criteria are met.
One criterion is that ambient concen-
trations should be adequate surrogates for
individual exposure. A single monitor for a
city population does not provide informa-
tion on personal exposure. In the sixth year
ofthe Six Cities study, extensive indoor and
outdoor monitoring for respirable size parti-
cles showed that indoor levels were signifi-
cantly different from outdoor concentra-
tions, and only a fraction of outdoor res-
pirable PM was penetrating indoors. The
differences were such that people "living in
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Table2. Demonstration ofecologic fallacy in comparisons of individual-level and group-level mortality risk estimates
Cardiopulmonary
Total mortality mortality
Toxicity ofPM2.5vs. Risk/ Toxicity ofPM2.5vs.
Results Exposure (pg/m3) RR Risk/ 20 pg/m3 tobacco smoke8 RR 20 pg/m3 tobacco smoke"
Group level(ecological):
ambientPM2.5
Six Cities 18.6 1.26 1.28 299 1.37 1.40 339
ACS 24.5 1.17 1.14 147 1.31 1.25 225
Individual-level (cohort):
25 pack-year smoker (average tar)
Six Cities 16,700 2.00 1.0008 _ 2.30 -
ACS 16,700 2.07 1.0009b _ 2.28 1.003b
Abbreviations: RR, relative risk; PM25, particulate matter <2.5 pm in aerodynamic diameter; ACS, American CancerSociety. SeeAppendix Aforfurther calculations.
`Toxicity of PM2.5 versus tobacco smoke: divide estimate of group-level (G1) PM25 risk per 1 pg/m3 (= group-level coefficient) orPG, by estimate of individual-level (IL) tobacco smoke risk per 1 pg/iM3 tar(orPIL3, or
PGU,IL. Forexample, using total mortality in the Six Citiesstudy: PGL = In RR 1.26/18.6 pg/m3 = group-level P coefficient forPM25 and total mortality in the SixCitiesstudy;PIL = In RR2.00/16,700pg/m3 = individual-level
1 coefficientfor cigarette smoke; siGLPIL= 299.
bifPM2.5were astoxic astobacco smoke, whatwould RR be? To estimateP coefficientfortobacco smoke(PIL), multiply byPM2.5 exposure difference between high and low polluted cities, and calculate RR. For example:
e(IILx 18.6pg/m3) = 1.0008fortotalmortality inthe SixCitiesstudy.
a 'clean' city, as defined by ambient levels,
may be exposed to levels comparable or
higher than those ofpeople living in a 'pol-
luted' area due to indoor air pollution lev-
els. In this way subjects [in the Six Cities
cohort] may be misclassified as to expo-
sure," and bias the results because it is not
known whether those who died were also
exposed to higherlevels ofPM2.5 (13).
In one of the Six Cities (Kingston/
Harriman), personal exposures were higher,
had a greater variance than outdoor con-
centrations, and were uncorrelated with
outdoor concentrations (14).
Data from other cities also show that
outdoor concentrations are poor surrogates
for personal exposure. Ozkaynak et al. (15)
concluded that outdoor sources in
Riverside, California, could only explain
about 16% of the variance in personal
exposure; thus, it "does not seempossible to
use outdoor measurements alone to reliably
predict personal exposure to PM10." Mage
and Buckley (16), in a review of the rela-
tionship between personal PM and ambient
PM, concluded that variations in ambient
PM "may have small influence" on individ-
ual personal exposure. Further, this lack of
correlation has "significant implications"
for "an ecological relation... in a communi-
ty [time-series] or between communities
[prospective]" (16). Brown et al. (17)
reported undetectable to weak or marginal
associations between personal exposure and
outdoor concentrations ofPMIO andPM2.5
in four U.S. cities, and study subjects in
two ofthe cities (Nashville and Boston) had
moderate to severe chronic obstructive pul-
monary disease. These authors concluded
that the inability to reliably predict personal
exposures based on outdoor concentrations
is inconsistent with acausal association.
Ambient PM as surrogatefor total PM
exposure (EPA argument). Average ambient
PM2.5 concentration was used as one ofthe
indices of "exposure to combustion source
ambient particulate air pollution" (4). The
EPA (18) suggested that ambient PM is an
appropriate surrogate, that it adequately
characterizes personal exposure to ambient
PM, that there is a clear "relationship
between health outcomes and ambient PM
concentrations," and, therefore, it is "rea-
sonable to presume that reduction in ambi-
ent PM will help to protect the public from
adverse health effects associated with per-
sonal exposure to ambient PM."
The EPA (18) argued that nonambient
PM exposures vary independendy ofambient
PM. Ambient PM is "expected to be a major
portion ofthe ambient PM measured in a per-
son's residential area" and is expected to be a
major portion of personal exposure. Thus,
nonambient PM "would probably not be a
confounder in epidemiologystudies" butcould
be an independent risk factor (18). Because
ambient PM isnotcorrelatedwith nonambient
PM, "epidemiological studies relating health
outcomes to ambient PM would not provide
any information about the health effects that
may be caused by [nonambient] PM" (18).
The only salient factors then, are that "there is
a relationship between health outcomes and
ambient PM," and there is a relationship
between "ambient PM... andpersonal orpopu-
lationexposure toambientPM" (18).
There are two crucial assumptions in
this argument: one is that ambient PM
must constitute a major proportion oftotal
PM exposure, and the second is that there
is a constant proportionality between ambi-
ent and personal exposure to PM. While
these assumptions may be met for non-
smokers living in residences without major
indoor PM sources, they are not met for a
large proportion of the rest of the popula-
tion, in particular, the populations studied
in the ACS and Six Cities cohorts.
Table3. Statisticsfrom stepwise regressions iden-
tifying significant independent variables in pre-
dictingthe dependentvariable personal exposure
Level R2 Independentvariables
1 <1% AmbientPM
2 16% AmbientPM + cigarettesmoke
3 17% Level2+time athome,time atwork,
timetraveling,time in public,othertime
4 51% Level3+indoorPM
Datafrom Spengler etal. (14).
The basis for these conclusions can be
derived from the argument developed bythe
EPA (19) and outlined below [comments in
brackets havebeen addedbytheauthor]:
1. Personal exposure to total PM is a criti-
cal parameter when analyzing individual
health outcomes. [To use group-level
exposure data in place ofindividual-level
data can produce biased results charac-
teristic of the ecologic fallacy. Also, see
Table 2.]
2. Ambient PM is a surrogate for personal
total PM exposure and therefore is a sec-
ondarysurrogate for PM dose.
3. Ambient PM is a suitable surrogate to
personal exposure "ifambient concentra-
tion was also linearly related to the per-
sonal exposure." However, treating ambi-
ent PM as a "surrogate for total exposure
to PM from all sources... would be
wrong. [The EPA also argues that ambi-
ent PM and nonambient PM vary inde-
pendently, in which case the relationship
cannot be linear. Thus, the concepts of
independence and linearity of ambient
and nonambient PM are incompatible.]
4. Personal exposure to PM ofambient ori-
gin is a poor surrogate for total personal
PM exposure (ambient PM + indoor
PM) "for those people whose personal
exposures are dominated by indoor (resi-
dential and occupational) sources such as
environmental tobacco smoke (ETS)."
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ETS adds on the order of25-45 pg/m3
to 24-hr average personal exposures and
residential environments where smoking
takes place.
Spengler et al. (14) compared per-
sonal exposure measurements to simulta-
neouslycollected home and outdoor con-
centrations of respirable particulates in
Kingston, one of the towns included in
the Six Cities study. Step-wise regression
models were evaluated to identify signifi-
cant predictors ofpersonal exposure. The
square of the multiple correlation coeffi-
cient (X2) was used to evaluate predictive
power. M2 values can range from 0% to
100%, and the larger the 12, the greater
the predictive value. For example, in the
Level 1 model (seeTable 3), ambient PM
alone explained <1% of the variance in
personal exposure, so this model had "no
predictive power." Three additional pre-
dictive models (Levels 2 through 4) were
analyzed. By adding more independent
variables, theX2values increased.
Indoor PM alone explained 47% of
the variance ofpersonal exposure overall.
The predictive power ofthe fourth-level
model varied with different subgroups in
the population (i.e., 20% for employed
subjects from nonsmoking households to
84% for nonemployed subjects from non-
smoking households). Spengler et al. (14)
conduded that "misclassification and mis-
association of exposures...are likely to
result...[when] relying upon ambient com-
munity-basedpartidemeasurements."
Smokers are usually excluded in
these assessments, and personal monitors
do not measure directly inhaled main-
stream tobacco smoke. Thus, nonsmok-
ers comprise essentially the only group
for which correlations of ambient/per-
sonal exposure have been assessed (19).
For many nonsmokers, ambient PM
comprises only a small proportion of
personal PM exposure, thus the first
critical assumption is not met.
5. For a smoker, ambient PM concentra-
tion is an even poorer surrogate for per-
sonal exposure because the several mil-
ligram amounts ofdirectly inhaled ciga-
rette smoke by an average smoker "can
be two to three orders of magnitude
greater" than the microgram amounts of
ETS that the personal monitor captures
(19). The personal exposure of"dusty-
trade workers can also be several orders
ofmagnitude greater than their exposure
to indoor particles of ambient origin"
(19). The "inhalation of mainstream
tobacco smoke will be a major additive
exposure to PM for the smokers, which
dwarfs the nonsmokers" personal expo-
sure monitor PM exposure (19). A
major proportion ofthe U.S. population
(e.g., smokers) has a total exposure to
PM that is at least "one order ofmagni-
tude greater" than that ofthe nonsmok-
ers (19). [Thus, ambient PM comprises
a negligible fraction of total personal
exposure to PM and is not linear when
nonsmokers, exposed nonsmokers, and
smokers are considered.]
6. Ifthevariance ofpersonal PM exposures,
which is uncorrelated to ambient PM
(e.g., from indoor sources, traffic, occu-
pational, ETS) among nonsmokers, is
very large, the percentage ofthe variance
ofpersonal PM that can be explained by
the variance in ambient PM will be very
small (19). [This is the case in most of
the studies cited by the EPA (19) in their
Table 7-26. When personal exposure to
mainstream tobacco PM is taken into
account, ambient PM explains even less.
Inhalation ofmainstream tobacco smoke
outweighs the sum of all other indoor
and outdoor PM exposures and "may
have an important implication for inter-
pretation of epidemiology studies that
relate ambient PM...to mortality or mor-
bidity" (1)]. Ambient PM is a surrogate
for personal exposure to ambient PM,
but because ambient PM comprises a
variable, and often quite small, propor-
tion oftotal personal exposure to PM, it
"would be wrong" to treat ambient PM
as a surrogate for total personal exposure
to PM (19). [To consider ambient PM
without considering personal exposure to
PM is also wrong.]
In sum, total personal exposures to
PM2.5 are critical in assessing the associa-
tion of PM exposure and mortality and
morbidity. Ifambient PM2.5 is a surrogate
for total personal exposure [as argued by
the EPA (19)], then ambient PM25 should
be linearly related to personal exposure and
not be "dwarfed" bynonambient sources of
PM2.5. Because neither of these assump-
tions is satisfied for a "large proportion of
the population," ambient PM is not an
adequate surrogate exposure variable.
Lifetime estimates ofexposure. Another
criterion necessary for valid use ofambient
concentrations as long-term estimates of
cumulative exposure is that ambient concen-
trations must have remained relatively con-
stant for several decades. Outdoor concentra-
tions in the Six Cities and ACS cohorts are
available foronlya fewyears. During the life-
time ofcohort members, ambient concentra-
tions were changingand were probablyhigh-
er in the past than recendy. For example, in
the ACS cohort, the 1979-1983 ambient
concentrations were considered representative
oflong-term cumulative exposure, but they
are unlikely to be representative of dirtier
cities for even the previous decade, when
there was extensive cleanup. The total sus-
pended particulate (TSP) was reduced by a
factor oftwo in New York City, for example
(19). Darlington et al. (20) reported that
there were significant reductions in PMIO
from 1988 through 1995. Nationwide, the
weighted annual average was reduced about
24% (34 pg/m3 to 26 pg/m3). In nonattain-
ment areas, the 7-year reduction was about
25%, compared to about 20% in attainment
areas. The average reduction in the anthro-
pogenicportion ofPM0O (primarilyPM2 ) is
between 27% and 33%. The effect o?an
underestimate ofexposure concentration is to
spuriouslyinflate theriskestimate.
Geographic mobility. A third criterion
is that account should be taken of both
long-term and short-term geographic
mobility. Long-term mobility refers to
moves of residence or workplace to differ-
ent cities. Short-term mobility refers to
working at a location different from one's
residence for each working day, and not
working on weekends (12). Geographic
mobility has been addressed in the SDA
cohort by interpolating monthly monitor
data to the zip codes ofthe home andwork
locations (5,6).
A related criterion is that exposure esti-
mates should include a significant portion
of each individual's life span. This is not
the case because ofthe limited time period
when PM2.5 was sampled. The ambient
PM25 concentrations were only measured
for 6-9 years in the Six Cities study and 4
years in the ACS study. For a person 74
years old at entry into the Six Cities cohort
who died the first year offollow-up, ambi-
ent PM25 concentrations would be for 2
years (1977-1979) or 2.5% of lifetime,
and part of the association would be for
exposures occurring after death. For a per-
son 25 years old at entry who died at the
end offollow-up (age = 40 years), ambient
PM25 concentrations would be available
for 10 years (25% oflifetime). In the ACS
cohort, the cumulative exposure is only
available for the years 1979-1983 and fol-
low-up is for September 1982-December
1989. The minimum and maximum frac-
tion oflifetime for which ambient concen-
trations are available are less than 1.4% (for
a 74-year-old at entry who died in 1982)
and 11% (for a 30-year-old at entry who
died in 1989 at end offollow-up).
Finally, account should be taken ofdif-
fering individual lifestyles, such as time
spent outdoors. This problem has been
addressed in the SDA cohort by adjusting
ambient mean concentrations to reflect
time spent indoors and in transit according
to indoor penetration factors (12).
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Summary. In summary, the Six Cities
and ACS prospective cohort studies are
unable to evaluate the effects oflong-term
exposure on mortality because 1) ambient
concentrations were not measured long
enough before death to meet the temporality
criterion for causality; 2) ambient PM is only
a small proportion oftotal PM exposure for
the majority of the population and will
therefore be overwhelmed by effects oftotal
PM exposure; 3) ambient PM concentra-
tions have declined for the last several
decades; 4) lifetime residences are not
known; and 5) there are no available esti-
mates oflong-term cumulative exposure as
ambient concentrations are available foronly
afraction ofalifetime (rangeof<2%---25%).
Thegroup-level estimates ofPM25 expo-
sure compared to lifetime cumulative expo-
sure to tobacco smoke in the Six Cities and
ACS cohorts show a marked difference in
both the adequacy ofthe exposure estimates
and in the estimated toxicity ofPM2.5' The
(concentration x time) exposure metric for
tobacco smoke is in pack-years. In both the
Six Cities and ACS cohorts, the risk ratios
(RR) for smokers were estimated for a 25
pack-year smoker. These datawill be used to
test the PM25 hypothesis by comparing esti-
mated risk of ambient PM25 air pollution
withthatoftobacco smoke.
Lack of Consistency and
Demonstration of Ecologic
Fallacy
To verify findings based on the ecologic
study design, individual-level exposure data
in studies relatively free of bias are needed
(9,11,21,22). Such a comparison ofindivid-
ual-level study results was implied in Hill's
(8) consistency criterion for causality and
demonstrated in the consistent associations
from over 30 individual-level cohort and
case-control studies ofmortality and smok-
ing in the 1964 Surgeon General's report on
smoking (23). Individual-level studies rela-
tively free of bias will be the standard used
to evaluate the validity ofthePM2.5 group-
level risk estimates. Such a reference stan-
dardshould meet several requirements:
* Individual-level data should be available
for both exposure and mortality. It is
helpful that both are available forsmokers
in the Six Cities andACS cohorts.
* A causal association should be well estab-
lished.
* Fine particulate matter from combustion
is a relevant type of PM, as it is consid-
ered among the most toxic components
ofPM2.5 airpollution.
Tobacco Analogy
Studies of mortality and tobacco smoking
meet the above requirements and provide
an appropriate standard for confirmation
or invalidation of the group-level PM2.5
risk estimates.
Individual-level estimates ofrisk.
Individual-level risk estimates ofthe associ-
ation between mortality (both total and
cardiopulmonary) and cigarette smoke are
available from both the Six Cities and ACS
cohorts.
Individual-level exposure to fine PM
from smoking a cigarette can be estimated
based on the following reasoning.
In 1957 the average tar content was 35
mg/cigarette (24). Tar content is defined
by the Federal Trade Commission (FTC)
as the total particulate in mainstream
smoke minus water and nicotine and is
determined by smoking cigarettes under
standard conditions in a smoking machine.
The typical smoker in 1980 smoked 32
cigarettes/day and inhaled 448 mg tar/day
(14 mg/cigarette x 32 cigarettes/day) (25).
At 18 m3 air breathed per day, the equiva-
lent average ambient PM2.5 concentration
was 24,900 pg/m3. [A time-weighted aver-
age 24-hr mean concentration is also an
average long-term exposure of a smoker
compared to nonsmoker and is analogous
to the difference in annual ambient PM25
concentrations between the most polluted
city versus the least polluted city.] In 1986,
about 47% ofsmokers bought high-tar cig-
arettes (.15 mg) and <3% bought very
low-tar cigarettes (<3 mg).
Analysis of tar content is usually based
on results from machine smokers, which
may underestimate tar content. For exam-
ple, the FTC method smokes at one
puff/minute, while the average smoker
inhales about two puffs/minute (26).
The range of tar in cigarettes is quite
wide, from a low ofabout 0.5 mg to above
35 mg. For comparison ofgroup and indi-
vidual-level risks, smoker exposures to ciga-
rettes containing 0.5 mg and 15 mg were
selected for illustrative purposes to provide
a range ofestimates ofexposure. The low-
tar cigarette provides the most conservative
estimate because it is smoked by only a
small proportion of smokers and has been
marketed for a relatively short time. At the
approximate midpoint of the Six Cities
study update, the average tar content might
have been about 15 mg/cigarette or higher.
Using a 15-mg tar cigarette as an average
for illustrative purposes underestimates
average exposure and is also a conservative
approach to illustrating the differences
between group-level and individual-level
estimates of risk. In the examples in this
report, 20 cigarettes/day will be used
because RRs in the Six Cities cohort were
for a smoker with 25 years ofsmoking 20
cigarettes/day (and 25 pack-years in the
ACS cohort) compared to a nonsmoker.
[Smokers who switch to lower (or higher)
tar cigarettes tend to take in somewhat less
(or more) PM, but less (or more) than
expected because ofcompensation (27).]
Tobacco smoke containsfine combus-
tionparticulate. Ambient PM25 is consid-
ered a combustion source particulate air
pollutant, and combustion source particu-
lates are considered important contributors
to early mortality (4).
Cigarette smoke PM is also a combus-
tion product and is a fine particulate ofres-
pirable size, much of it ofsubmicron size.
Particle sizes reported in the literature range
from 0.25 to 0.7 pm by mass median aero-
dynamic diameter and from 0.15 to 0.25
pmby count.Virtually 100% ofsmoke par-
ticles are in the respirable range (28).
Mortality is well characterized. The
risk of mortality from tobacco smoke is
well characterized in dozens of individual-
level studies as summarized in the Surgeon
General's reports on smoking (23,26), and
the causal association between smoking
and a number of diseases is generally
accepted.
Demonstration ofEcologic Fallacy
Because a "gold-standard" (individual-level
epidemiology studies of smokers) is avail-
able, we can now address the question: Are
group-level risk estimates ofPM25 toxicity
from the Six Cities and ACS cohorts com-
parable to individual-level risk estimates of
PM2.5 from cigarette smoke for total and
cardiopulmonary deaths?
The relative risks of total mortality for
25 pack-year smokers and an annual esti-
mated exposure of approximately 16,700
pg/m3 is 2.00 and 2.07 in the Six Cities
and ACS studies, respectively. For car-
diopulmonary mortality the RR are 2.30
and 2.28, respectively. These risks are
based on individual-level exposure data and
should be considered the reference value.
Group-level estimates ofrisk for total mor-
tality in the Six Cities and ACS cohorts are
1.26 and 1.17, respectively, for an estimat-
ed PM25 exposure ofabout 20 pg/m3. For
cardiopulmonary mortality the group-level
RR are 1.37 and 1.31, respectively.
Group-level estimates ofrisk suggest that
PM25 is about 150->300 times more toxic
than individual-level estimates of tobacco
smoke toxicity. If PM2 5 were as toxic as
tobacco smoke, the effect ofa 20 pg/m3 dif-
ference in PM25 exposure would be too
small to measure (Table 2; see alsoAppendix
1 for furtherdiscussion ofthesecalculations).
The individual-level risks ofexposure to
various pack-years ofsmoke (currentsmoker,
former, ever smoker) were also tabulated in
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the Six Cities and ACS cohort studies and
are compared to estimated group-level risks
ofambientPM2'5 (Fig. 1 and 2). Theoveres-
timates ofgroup-level risks are clearly seen,
especially in the ACS study where never
smokers have a slightly higher risk than ever
smokers although ever smokers have an
added burden ofnearly20,000 g/m3 tobac-
co smokeexposure (Fig. 2).
These data suggest that the true risk of
mortality from PM2,5 air pollution is
unknown and probably unmeasurable. The
estimated group-level risks of 1.17-1.40 are
small-but are not negligible, as expected if
PM2,5 were as toxic as mainstream tobacco
smoke. Nevertheless, they are implausibly
large compared to the smoking riskestimate
of 2.0-2.3, considering that smokers are
exposed to a presumably more toxic partic-
ulate at concentrations over three orders of
magnitude higher.
The group-level PM25 risk estimates
from the Six Cities and ACS cohorts are so
muchlarger than thereferencevalues thatthe
hypothesis is not confirmed, the test for con-
sistency is not met, and the PM25 risk esti-
mates from group-level data are invalidated.
IfPM2.5 were as toxic as tobacco smoke, the
differences in exposure between cities would
be too small to measure effects on mortality.
PM2.5 could be more toxic than tobacco
smoke, but there is no evidence forthis and it
seemsunlikely.
Interrelationships of Strength
2.0
of Association, %
Exposure-Response, and 0 1.5
Confounding
The presence of a strong association and a
biological gradient (exposure-response; E-R)
aresupportive ofa causal association. Aweak
association is one in which the ratio of the
frequencyofmortalitybetween high andlow
exposed groups is small in magnitude. A risk
ratio ofabout 1.50 (i.e., 50% increase) is a
weak association (29). In the Six Cities and
ACS cohorts, differences between cities of20
pg/m3 were associated with 28% and 14%
increases in total mortality, respectively. This
20-pg/m3 difference in concentration
between high andlowpolluted cities is about
0.1% ofPM2.5 exposure experienced by an
average smoker. Although the group-level
estimates suggest that PM2.5 may be several
orders ofmagnitude more toxic than tobacco
smoke, the exposure range is still too narrow
to reliably measure an effect, even at a high
level oftoxicity.
For an association to be reliable, it must
also berelatively free ofconfounding. Ifcon-
founding is present, particularly when the
association isweak, then the true E-Rassoci-
ation maybe indeterminable. Theweaker an
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Figure 1. Six Cities study: total and cardiopulmonary mortality rate ratios (individual-level versus group-
level estimates). Tobacco smoke PM2.5 is from 15 mg tar/cigarette with 20 pack-years for former smokers
and 25 pack-years for current smokers. Error bars indicate 95% confidence intervals.
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Figure 2. ACS cohort: total and cardiopulmonary mortality rate ratios (individual-level versus group-level
estimates). Tobacco smoke PM25 is from 15 mg tar/cigarette with 29.8 pack-years for ever smokers. Error
bars indicate 95% confidence intervals.
association, the more likely it is that bias,
confounding, or inappropriate analysis may
explain the association, and the greater the
need for a thorough understanding of the
underlyingbiological mechanisms (30).
Confounding
Confounding in these studies can occur
because of initial differences in major risk
factors between the cohorts in each city. In
the cohort study the mortality in different
study populations is compared and the dif-
ferences correlated with average PM ofeach
study population. Major risk factors associ-
atedwith increased mortalityshould be sim-
ilar among all study subjects and, if not,
they should be adjusted for in the analysis.
The analyses are similar to an experimental
study in which all exposure groups (or
cohorts in each city) are considered identical
exceptforexposure toparticulate matter.
Thus, confounders in the cohort study
are often different than in the time-series
studieswhere the changing mortality is corre-
latedwith changes in PM in a constantstudy
population. Important potential confounders
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in the time-series studies indude weather
(and factors that vary with PM). Important
potential confounders in the cohort studies
are differences in the distribution ofrisk fac-
tors among the cohorts in each city, such as
diet, socioeconomic status (SES), lung finc-
tion, physical activity, blood pressure, etc.
The objective that cohort members
from each city be essentially the same for all
important risk factors except for ambient
PM2.5 is not achieved, so there is confound-
ing. Two examples are discussed below.
Lungfunction. One example of con-
founding is lung function, specifically forced
expiratory volume in 1 sec (FEV1). Reduced
FEV1 is a risk factor for total, respiratory,
and cardiovascular mortality, even among
nonsmokers. In an 18-year prospective study
ofnonsmokers, the RRs associated with a 1-
liter decrease in FEV1 were 1.52, 4.16, and
1.49, respectively, and FEV1 was a stronger
predictor ofmortality than body mass index
or plasma cholesterol (31). In a 30-year fol-
low-up of men in Boston, Massachusetts, a
reduction of 1 liter in FEV1 was associated
with a 70% increase in total mortality and
was a more significant risk factor than cur-
rent smoking, total cholesterol, blood pres-
sure, orbody mass index (32).
FEV1 varies by smoking category and
by sex between cities in the Six Cities
study. Nevertheless, the between-city dif-
ferences in FEV1 are not due to differences
in PM2 5 pollution. For example, the
adjusted differences between nonsmokers
in Steubenville and Portage is 0.18 liters
(33). For ex-smokers, the differences in
FEV1 for males and females are 0.115 and
0.160, respectively, and for a smoker of a
pack per day or more are 0.112 and 0.145
liter, respectively [estimated from data of
Ferris et al. (34)]. Figure 3 graphically dis-
plays the potential effect of differences in
FEV1 between cohort members in the Six
Cities study. These are not precise esti-
mates because the distribution of smokers
in each city was not available, so it was nec-
essary to assume the same distribution of
smokers in each city (35). These results
indicate that lung function is a probable
confounder.
Sedentary living. Another example of
unadjusted confounding is sedentary living.
Lackofexercise is an independent riskfactor
for mortality. The population attributable
risk (PAR) is 13% forsedentaryliving (36).
Lipfert (37) evaluated mortality risk as a
function ofsedentary lifestyle in five ofthe
six cities and showed that it alone appeared
to be as good a predictor of mortality as
PM25. In a similar analysis, Lipfert (37)
plotted age and race-adjusted mortality ver-
sus PM2 5 for areas that roughly corre-
sponded to the 50 locations in the ACS
study. By adding additional nonpollutant
confounding variables (smoking, education,
overweight, ethnicity, water hardness,
sedentary lifestyle, poverty, migration) the
E-R slope was reduced considerably.
Because sedentary lifestyle was not adjusted
for in either study, it could possibly be the
cause ofthe apparent E-Rtrends forPM2.5.
Other considerations. It is important to
note that information on potential con-
foundingvariables in the Six Cities andACS
cohorts induded only age, sex, race, smok-
ing, education, overweight, exposure to pas-
sive smoke, and alcohol; in the ACS study,
occupational exposure was also included.
Adjustment may be inadequate for some of
these. For example, nonlinear instead oflin-
ear relationships may be more appropriate
for weight and alcohol; education is not a
good surrogate for SES of women, etc. The
EPA (19) also indicated that spatial con-
founding from unadjusted confounders, as
well as linear modeling for nonlinear effects,
has resulted in overestimates ofrisk.
Lipfert (37) concluded that the differ-
ences in mortality between cities are, in
part, dependent on the number ofpossible
confounders in the model. Thus, the asso-
ciations in the six cities and ACS cohort
studies may be due to the lack of adjust-
ment for important confounding variables
and not due to PM25. The adjustments by
Lipfert (37) are based on group-level data;
however, the lung function data from the
Six Cities cohort are individual-level data.
There may be other more appropriate
ways to assess strength of association and
causality. A single outcome, such as mortali-
ty, has multiple causes that relate to an indi-
vidual's total life history. Multiple causes
range from genotype anddevelopmental his-
tory to such risk factors as smoking, diet,
physical activity, and work and living envi-
ronment. The important question is: What
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major factors affect mortality, and what is
their relative importance?
For example, Spengler et al. (14) used
stepwise regression models and P2 to assess
the relative importance of ambient PM,
indoor PM, and time-activity patterns in
predicting personal exposure. Dockery et al.
(3) separated the data according to smoking
status, sex, and occupational exposure and
then evaluated the effect ofthese covariates
on the adjusted risk ratio for PM25.
However, risk ratios were used instead ofthe
more informative M values. These efforts are
a step in the direction ofamore global assess-
mentofimportant determinants ofmortality.
It is not dearwhether all possible combi-
nations were evaluated, and in the Six Cities
study not all risk factors (such as FEV1) were
included in the analyses. It is also not clear
why ambient PM is noninformative regard-
ing personal exposure, but is a significant
variable associated with mortality in the Six
Cities study. A more appropriate and infor-
mative approach is needed to achieve greater
understanding ofthe importance ofthese risk
factors. Use ofan approach such as regression
trees would be an improvement because it
allows possible combinations to be identified
in a model-free, tiered approach so the pre-
dictivepowerofallvariables canbeevaluated.
Given the very weak association with
PM25 and lackofadjustment for important
confounders, the true E-R relationship
between PM2.5 and mortality cannot be
determined in the Six Cities and ACS
cohort studies.
Coherence
Do the data conflict with generally known
facts ofthe disease? Are other health effects
observed? Are the ecologic risk estimates
coherent and consistent with individual-
level risk estimates?
Two approaches are taken in addressing
coherence. The first and most important is
to assess coherence of individual-level lung
function data, comparing the known effects
of tobacco smoke exposure to the predicted
effects ofPM25. The second approach is two
sided. On the one hand, I argue that coher-
ence cannot be assessed using other ecologi-
cal study designs, either time-series or
cohort. But, if one thinks ecologic study
results can be used to support other ecologi-
cal study results, then the SDA cohort is the
appropriate study because both mortality
andmorbiditydata areavailable.
ArguingCoherence Using
Individual-level Studies: Tobacco
Analogy
Several examplesfollowofhow the Six Cities
study conclusions on mortality are not
coherent with other knowledge, even with
individual-level morbidity data on lungfunc-
tionfromthe Six Citiesstudypopulation.
An appropriate place to evaluate coher-
ence is to evaluate changes in morbidity
within the cohorts. Again the tobacco analo-
gy is useful, this time for assessing the effects
oftobacco smoke on changes in lung func-
tion. Xu et al. (35) examined the lung func-
tion of Six Cities cohort members on three
occasions over a 6-year follow-up period.
Loss of pulmonary function [FEVI and
forced vital capacity (FVC)] depended "lin-
early on the number of cigarettes smoked
each day." Adjusted reduction in FEV1 and
FVC in men and women smoking 30 ciga-
rettes/day ranged from 4.1 ml/year to 12.6
ml/year. For 5 cigarettes/day (or about
4,000 jig/m31day exposure), the estimated
yearly change would be negligible (<1 ml).
The possible lackofa smoking effect among
lighter smokers is also supported by the sim-
ilarity in age-adjusted average rate ofchange
in FEV1 between nonsmokers and less than
15 cigarettes/daysmokers (see Fig. 4).
While these results may not be conclu-
sive for lifetime exposures because of short
follow-up, relatively high dropout rate, small
numbers, and variability in the data, the
results suggest that PM25 in ambient air is
unlikely to produce larger reductions in
FEVI than those experienced by a light
smoker exposed to about 6,000 pg/m3
tobacco smoke during the period of this
study. These data also suggest that the differ-
ences in FEV1 between cities are not due to
the small differences in ambient PM25. The
lack ofan apparent effect on FEV1 for light
smokers is not coherent with an increase in
mortalityassociated with much smallerexpo-
sures to PM25 airpollution.
Lifetime smoking data indicate a linear
relationship between cumulative cigarette
smoking measured as pack-years and irre-
versible loss of FEV1 and FVC in the Six
Cities study (38). The irreversible effect of
cumulative pack-years on height-adjusted
FEV1 is 7.4 ml/pack-year (-0.0004 ml/pgl
m3 cigarette smoke), plus an additional
reversible deficit of 123 ml for a total of308
ml over 25 years for a pack/day smoker. For
a 25 pack-year woman smoker, theestimated
effect ofcumulative smoking is 110 ml plus
a reversible deficit of 107 ml, for a total of
217 ml. This is about 9% of mean height-
adjusted FEV1 at 50 years ofage. Ifambient
PM2.5 air pollution is as toxic as cigarette
smoke (and nonsmokers have a similar
response as smokers), an 18.6 pg/m3 expo-
sure for 25 years would result in irreversible
loss ofabout 0.208 ml and areversibledeficit
of about 0.139 ml, or a total of 0.347 ml.
The equivalent losses for women are 0.124
ml, 0.121 ml reversible, or 0.245 ml total.
These estimated losses in FEV1 from 25
years exposure to an annual average of 18.6
lpg/mi3 are much less than 1% of height-
adjusted FEV1 and are too small to measure
with reliability. Theseresults are not coherent
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with the group-level estimates ofmortality, as
onewould expect alarger effect on morbidity
than mortality.
Cori and Mantel (39) suggested the
threshold at which significantly increased
risks of lung cancer, coronary heart disease,
and respiratory disease mortality can be
detected are about four to five cigarettes per
day. This is an average exposure of about
3,300-4,200 pg/m3 for a 15-mg tar ciga-
rette, or 150-210 times greater than the dif-
ference between high and lowpolluted cities.
These individual-level estimates ofrisk from
cigarette smoke are also not coherent with
thegroup-level estimates ofriskfromPM2.5.
ArguingCoherence Using
Time-Series Studies
Pope et al. (4) state that time-series studies
show that particulate air pollution is associ-
ated with declines in lung function,
increased respiratory symptoms, respiratory
hospitalizations, restricted activity due to
respiratory illness, and increased mortality,
especially respiratory and cardiovascular
mortality. They suggest this "coherent cas-
cade of cardiopulmonary health effects"
enhances biological plausibility of the
cohort mortality studies.
Use oftime-series studies to support the
coherence criterion is not appropriate. The
questions addressed by time-series and
prospective studies are different. Time-series
studies attempt to answer whether individu-
als already sick with preexisting cardiorespi-
ratory illness die because of episodes of
short-term elevations in air pollution.
Prospective cohort studies address the ques-
tion ofwhether long-term exposure ofpri-
marily healthy individuals increases the risk
of total and cardiopulmonary mortality.
Dockery et al. (3) conduded that "because
the daily time-series studies evaluated only
the effect ofshort-term changes in pollution
levels, whereas our study [Six Cities] evalu-
ated associations with long-term exposure...,
quantitative comparisons with these investi-
gations aredifficult to make."
Arguing Coherence Using Other
Group-level Studies
It is a circular argument to use other eco-
logical studies to test or validate either the
consistency or coherence criteria. Ecologic
studies are subject to similar biases and, in
general, lack the rigor to test the hypothe-
sis. If one does not accept this reasoning
and uses ecological studies to assess the
coherence criterion, the SDA cohort study
and lung function data on children in the
Six Cities study are the logical places to
address the question ofwhether both mor-
tality and morbidity are associated with
PM in the same cohort.
Table 4. Symptom changes in the Seventh DayAdventiststudy, 1977-1987
New cases Persistent Reversal
RR (n) (n) (n) Percent reversal
AOD p<0.05 330 317 163 34%
Asthma p>0.05 87 126 130 51%
Chronic bronchitis
Cough type p<0.05 180 125 107 46%
Sputum type p<0.05 281 157 139 47%
Abbreviations: RR, risk ratio;AOD, airway obstructive disease.
Seventh Day Adventist cohort. The
SDA cohort contained no smokers (only
nonsmokers and ex-smokers and included
respiratory symptom data as well as mortal-
ity information over a 10-year period. The
bulk ofthe study participants were in three
areas in California (Los Angeles, San
Diego, and San Francisco) (5,6). Exposure
estimates included length of residence and
more than one area monitor per person,
and accounted for time spent at place of
residence and job, as well as environmental
tobacco smoke exposure. In a series of
reports on the SDA cohort, awide range of
air pollutants besides PM were also
assessed. In the SDA cohort, exposure is
closer to individual-level exposure than in
either the Six Cities orACS cohorts.
In the SDAcohort, the RRfor mortality
associated with PM10 was not significant
and was said to be around 1.0 (6). The RR
for mortality associated with PM25 (based
on visibility) was "close to, orless than, one"
(6). The relative riskofdeveloping new cases
ofairway obstructive disease (AOD), chron-
ic bronchitis, and chronic productive cough
were significantly associated with PM1O (RR
= 1.17). The association was not significant
forasthmaorcough (5).
The lack ofan association for mortality
is not consistent with the Six Cities and
ACS cohorts. The presence of an associa-
tion for morbidity, but not mortality, does
not provide a coherent argument for mor-
tality. However, morbidity is the more sen-
sitive indicator ofan effect, which is consis-
tentwith the coherence criterion (40).
Even the association with symptoms is
problematic. Logistic regression results
were provided for new cases of AOD,
chronic bronchitis, and asthma. However,
reversal ofthese symptoms also occurred, as
34% to 51% of the symptoms went away
between 1977 and 1987 (Table 4).
IfPM is also associated with reversal of
symptoms, a causal association is unlikely
because it is hard to imagine that PMIO air
pollution could be causally associated with
both new symptoms and reversal of symp-
toms. Separate analyses to account for
reversibility ofsymptoms should analyze the
correlation of 1977-1987 PM1O concentra-
tion with new cases and with symptom
reversals to see ifthere is a positive associa-
tion with the former and a negative associa-
tion with reversals. These results are not
reported.
Finally, the PM1O group-level risk esti-
mates for AOD and chronic bronchitis are
over 40 times greater than the estimates
based on individual-level smoking data from
the same cohort (seeAppendix 2). Thus, the
group-level PM1O risk estimates for symp-
toms in this cohort appear to behigh.
Six Cities cohort. Several studies have
assessed the respiratory health ofchildren in
the Six Cities study (41,42). Both evaluated
the same cohort of preadolescent school
children, but PM25 measurements are avail-
able only for the later study (42), which was
analyzed as a cross-sectional study and used
12 months of PM25 data as the exposure
variable (annual mean). Relative odds were
calculated comparing the most polluted
(Steubenville) and least polluted (Topeka)
cities after adjustment for sex, age, maternal
smoking, and use ofa gas stove. There were
no signiflcant associations of respiratory
symptoms or lung function with PM2.5
(except hay fever, which showed a negative
relationship). RR estimates were elevated
about twofold for bronchitis, chronic cough,
and chest illness. The widest 95% confi-
dence interval (CI) and highest RR was for
chronic cough (RR = 2.3; CI = 0.4, 13.2).
Therewas "no evidence for an effect" ofpol-
lution exposure on any measure of lung
function, even in children with persistent
wheeze, despite use ofpotentially more sen-
sitive measures of small airways response
than FEV1 and FVC (42). Children general-
ly spend more time outdoors than adults
and have a greater specific ventilation (liters
perkilogram bodymass).
The adjustments for potential con-
founders may not be adequate. For exam-
ple, the RRs were not adjusted for season,
although the RR for bronchitis associated
with PM15 was reduced from 2.52 to 1.97
when such an adjustment was made. Also,
Dockery et al. (42) suggested that effects of
acute exposure occurring before examina-
tion may have masked any chronic effects.
The cross-sectional study design may not
provide suffilcient power to detect signifi-
cant differences.
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Figure 5. Percent mortality in lifetime exposure of rats to diesel exhaust. Abbreviations: M, male; F, female.
The dashed line indicates controls.
Data from Ishinishi atal. (48).
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dData from Heinrich etal. (54).
Summary
The coherence and consistency criteria
were not met using either individual-level
or ecological-level data. The individual-
level data suggested a possible threshold
effect at or below about five cigarettes per
day on lung function (from Six Cities
data), as well as coronary heart disease and
respiratory disease mortality (39). The
PM2.5 concentration difference between
high and low polluted cities was more than
two orders ofmagnitude below the thresh-
old, and any effect of the long-term expo-
sure to these concentrations on lung func-
tion was undetectable.
Using group-level data from the SDA
cohort, the coherence criterion was not met
because 1) there was no PM2 5/mortality
association; 2) the PM10/symptom associa-
tions showed an implausibly high strength
ofassociation; and 3) the long-term biolog-
ical significance of the symptoms was
undear, given the high frequency ofsymp-
tom reversal and the lack of any analysis
showing no association between PM25 and
symptom reversal.
Biological Plausibility
Are the results biologicallyplausible and do
they agree with current understanding of
how organisms respond to low concentra-
tions ofPM?
Plausibility is not arequired criterion to
demonstrate causality. However, ifecologic
study designs are being used to both gener-
ate and test the hypothesis as well as for
risk assessment, then biological plausibility
takes on added importance. An increased
level of proof is required because ecologic
studies are subject to the ecologic fallacy,
and the smoking analogy indicates large
overestimates ofrisk.
There appears to be general agreement
that no plausible mechanism is presently
available to explain the associations
between chronic exposure toPM2.5 air pol-
lution and increased mortality. Pope et al.
(4) indicated that additional research is
needed to "help a toxicologic framework
for interpreting these [ACS] findings."
The hypothesis predicts that long-term
exposure to fine particulate should increase
mortality. There are experimental data of
lifetime exposure ofanimals to fine particu-
late matter showing no increased mortality
even though exposures are so high as to pro-
ducelungoverload (submicron diesel partic-
ulate was used as the fine particulate).
Exposure was adjusted to reflect average
168-hrweeklyexposures, which is analogous
to an annual average. Despite average con-
centrations of diesel exhaust particulate up
to 100 times higher than the most polluted
city in the Six Cities study, mortality was
not increased (43) (seeAppendix 3 and Fig.
5, which summarize these results). These
concentrations are so high that overloading
occurred, causing reduced clearance,
increased retention of particulate matter,
and increased lungburden.
Green and Watson (44) reviewed exist-
ingdata regarding issues critical in evaluating
thetoxiceffects ofsmall PM (primarilydiesel
exhaust) at ambient levels. I have summa-
rized their major points as they relate to the
biological plausibility ofPM2.5 air pollution.
Retention ofPM in the lungincreases in the
working environment as milligram per cubic
meter PM concentrations increase (as in
pneumoconiosis). Lung overload occurs
when the deposition of PM over extended
periods oftime overwhelms lung dearance
and occurs only at higher exposures. Because
the relationship of exposure and retention
may not be linear, the lung burdens at low
exposure concentrations are less than would
be predicted based on linear extrapolation
from high PM exposures. Models based on
experimental data predict that lung dearance
dedines as continuous exposure (24 hr/day,
7 days/week for 1-10 years) increases from
100 gg/m3 to 1,000 pg/m3. Under continu-
ous exposure conditions, the models predict
no reductions in alveolar dearance ofdiesel
particulate in adults or children below daily
concentrations of 50 pg/m3. The models
predict that ifexposure is intermittent, dear-
ance overload would not occur at concentra-
tions below 1,000pg/mi3.
Human exposure is likely to be inter-
mittent, and concentrations ofPM25above
even 50 pg/m3 are unlikely to occur. The
95th percentile daily concentration in the
Six City study was 43 pg/m3 (45). Thus,
impaired dearance and increased lung bur-
den due to PM2 5-induced overload are
unlikely to occur.
Pritchard (46) suggested that overload
also occurs in humans when human expo-
sures are such that lung burdens approach
those seen in animal experiments. It has
been estimated that smokers of25 middle-
tar cigarettes (18 mg) per day with some-
what reduced clearance rates would achieve
a lung burden such that tar clearance and
deposition would be in equilibrium (46).
By this estimate, overload in a heavy smok-
er would occur with exposure to daily con-
centrations of about 25,000 pg/m3 main-
stream tobacco smoke.
In sum, there is evidence that chronic
exposure concentrations of PM25 several
orders of magnitude higher than ambient
air concentrations may have little effect on
mortality in experimental studies of
rodents. Survival is similar at low exposure
levels and under conditions of lung over-
load when compared to control exposures.
Thus, there appears to be a no-effects
threshold. There is little support for the
plausibility of lifetime PM2.5 exposures in
microgram per cubic meter concentrations
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causing increased mortality in humans
based on experimental exposure in rodents.
Risk Assessment
Hertz-Picciotto (47) suggested a classifica-
tion framework for using epidemiological
studies in quantitative risk assessment and
in setting air quality standards. These clas-
sifications are briefly summarized in Table
5, along with comments pertaining to
whether the PM2.5 studies meet the sug-
gested requirements. The EPA (18) endors-
es the use of these criteria in contributing
to the weight-of-evidence determination of
ahuman health hazard.
The EPA position on the need for
individual-level exposure data is somewhat
ambiguous. The EPA only has regulatory
authority over outdoor air and argues that
variations in ambient PM are reflected in
variations in personal PM exposure and
that ambient PM is "hypothesized to cre-
ate the health effects" (18). Therefore,
reduction in ambient PM will "help to
protect the public from adverse health out-
comes associated with personal exposure to
ambient PM" (18). Thus, there is no need
for E-R trends based on individual-level
exposures.
The opposing side to this argument is
discussed primarily in the section on eco-
logic study design. The contribution of
ambient PM to personal PM is small for a
majority of the population, and the health
effects are probably too small to measure in
individuals or populations. The EPA has
also presented statements suggesting that
quantification of individual-level exposure
may be necessary. Personal exposure is said
to be "important in itself, because the body
may react differently to ambient and non-
ambient particles" (1p). Personal PM may
act as a confounder in ecological studies,
and personal PM is a "critical parame-
ter...[when] health outcomes are being
tracked individually" (19).
As shown in Table 5, none ofthe Hertz-
Picciotto criteria for quantification of risk
and setting air quality standards using epi-
demiologystudies are met.
The first and fifth criteria are the
strength ofassociation and biological gradi-
ent causal criteria outlined by Hill (8).
These were discussed above where it was
suggested that the group-level strength of
association was exaggerated and the biolog-
ical gradient (E-R) could not be deter-
mined because of uncontrolled confound-
ing and inadequate estimate of exposure.
The third criterion is not met because it is
likely that various factors may be con-
founding the associations reported in the
Six Cities and ACS studies. Physical inac-
tivity and FEV1 were identified as two
Table 5. Criteria for using epidemiology studies in quantitative risk assessment
Criteriaa
Moderateto strong positive
association present
Strong biases ruled outor
unlikely; includes
consideration ofstudy
design,validityof measure
ofexposure, and outcome
Confounding controlled or
likelyto be limited
Quantification ofexposure
linkedto individuals
Monotonic
E-R relationship
Requirement& Does prospective cohortdesign meetthe criteria?
Necessary Unlikely: Strength ofassociation in prospective cohortstudies
isweak, and riskis an overestimate asdetermined byvalidity
checkwith individual-level datafrom smokers. Inthe SDA
study,there is no associationwith PM.
Necessary No: Exposure misclassification bias isverylikelyand
ecologicalfallacyprobable. Ecologicalstudydesign is
inappropriatefortesting hypothesis orevaluating E-R and
requiresindividual-level designto assessconsistencyof
results. Riskestimates are overestimates in SixCitiesand
ACSstudies asdetermined bycomparison ofindividual-level
data from smoking data.
Necessary No:There are substantial differences between cities in risk
factorsthatare notadjustedforintheanalysis(e.g.,physical
activity,diet, blood pressure,SES).These differences could by
themselves explainthe difference between high and low
polluted cities.
Necessary No: Exposure is based onsingle numberforall inhabitants
ofthe studyarea and isthus a group-level measure and not
linked to anyindividual.The prospective cohortmortality
studies need a cumulative exposure estimatethatincludes
both concentration andtime.The estimates used have notime
variable,onlyaverage concentration,which has changed
overtime.AmbientPM,. isformanyindividualsonlya small
proportion oftotal PM25 exposure and maythereforewash out
possible effects ofambientPM25.
Notnecessary, Can'ttell: E-R relationship cannotbe determined because
butadds exposure is misclassified and confounding is present
certaintyto
riskestimates
Abbreviations: SDA, Seventh Day Adventists; PM, particulate matter; E-R, exposure-response; ACS, American Cancer
Society; SES, socioeconomic status.
&Criteria and requirement from Hertz-Picciotto (47).
examples of confounders. Issues of con-
founding and other biases increase in
importance when an association is weak, as
it is for PM air pollution. The fourth crite-
rion is that individual-level exposure data
are necessary to avoid the possibility of
exposure misclassification bias and the eco-
logical fallacy. There are no individual-level
exposure data to determine whether per-
sons with increased mortality also have
increased PM2.5 exposure. Because group-
level exposure cannot be linked quantita-
tively with individuals and is often only a
small proportion of total exposure, the
fourth criterion is not met. Not only are
none ofthe criteria met, the risk estimates
for ambient PM2.5 appear to be biased
upward.
Summary and Conclusion
Several aspects of the prospective cohort
studies ofPM2.5 air pollution (3,4) render
them susceptible to error in estimating
individual risk and suggest that the associa-
tions may be statistical and not causal.
Group-level exposures make these
prospective cohort studies susceptible to error
in estimating individual risk. Ambient expo-
sure is poorly correlated with personal expo-
sure. Differences between individuals in the
same city are larger than individual differ-
ences between cities. Long-term changes in
airpollution levels are not reflected in group-
level exposure estimates. Exposure to main-
stream and possibly sidestream cigarette
smoke probably masks out any potential to
measure exposure effects to ambient PM2.5. Ambient concentrations do not reflect per-
sonal exposure on a day-to-day or year-to-
year basis, do not reflect long-term or life-
time exposure, and are often only a small
portion of total personal PM2 5 exposure.
Ambient concentrations were measured too
close to time ofdeath to be causally linked to
chronic mortality. Thus, the temporality cri-
terion, the one criterion that must be met to
establish causality, is not met.
The PM2 RRs for total and cardiopul-
monary mortality are orders ofmagnitude too
high when tested using the tobacco analogy.
That is, group-level data from the Six Cities
and ACS cohorts suggest that PM25 is
35-1,000 times more toxicthansmoke from a
low-tar cigarette on a weight/volume basis.
This is a conservative estimate, as most smok-
ers smoke cigarettes with more tar, and low-
tar cigarettes have been available only recently
in thelifespan ofstudysubjects.
Even ifPM2.5 were as toxic as cigarette
smoke PM, the prospective studydesign could
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Table 6. Summary ofweight ofevidence regarding a causal association
Criteria Effects on causal hypothesis
Chance Supports because statistical significance is achieved
Confounding Detracts due to inadequate adjustment for potential confounders
Bias Detracts, with misclassification of exposure as best known bias
Strength of association Detracts because association is weak due, in part, to very low exposure (risk = exposure xtoxicity)
Exposure-Response Detracts because trends are not plausible based on comparison with individual-level smoking data
Consistency Detracts because results are contraryto individual-level studies ofsmokers
Coherence Detracts because morbidity (pulmonaryfunctiontest) should showstronger association than mortality
Analogy Detracts, as risk is overestimated compared to tobacco combustion products
Biological plausibility Detracts because there is no increased mortality of animals exposed for lifetime to high concentrations of combustion products
Temporality Eliminates possibility of causal associations because estimates of exposure either do not precede disease or do notprovide
adequate latency
not detect a measurable difference because of vide both theoretical and demonstrated rea- PM often show no reduction in life span,
the relatively small concentration differences sons for questioning the validity of the E-R even though overloading results in reduced
between high andlowpolluted cities. trend. The tobacco analogy demonstrations clearance. Overloading and lung burden in
Confounding from variations in risk fac- ofgross overestimates ofthe RRs areexamples humans are improbable events at low micro-
tors between cities requires adjustments that ofthe ecologicfallacy. gram percubic meter concentrations in ambi-
have not been made. At least two confounders The coherence criterion is not met because ent air.
(physical inactivity and FEV1) have been iden- the ambient PM25 concentrations are too low In sum, the prospective cohort studies
tified that appear to bias the PM2 5 risk esti- to produce a measurable effect on lung func- investigating the association ofmortality and
mates away from the null. Analysis ofindivid- tion. Changes in lung function are considered chronic exposure toPM2.5 do notdemonstrate
ual-level lungfunction data from the Six Cities to be more sensitiveindicators ofadverseeffects a causal association with increased mortality.
cohort shows that the effect ofambient PM2,5 than death. Thus, because the small differences Riskestimates from thesestudies are exaggerat-
is toosmall tohave an independentmeasurable in PM25 between high and low polluted cities ed, and these investigations do not meet the
effect on FEV1. Thus, the observed association do not produce measurable differences in lung criteriaforaquantitativeriskassessment.
of PM25 and mortality may be in large part function, it is unlikelythat theywouldproduce Theweightoftheevidence is notsufficient
explainedbyunadjusted confounding. measurabledifferences inmortality. to support the hypothesis ofa causal associa-
The biases inherent in group-level esti- The plausibility criterion is not met tion (Table6).
mates ofexposure (exposure misclassification because rodents exposed for a lifetime to high
bias) and the unadjusted confounding pro- concentrations of a mixture containing fine
Appendix 1
Methodology and ample calculations for comparing rsk esmat baed on exposru andindi-
id Six cohorts
Both Six Cities and ASstudies show .sinficat associations b n average PM25 con atn and mortalityer adjustment
forindividual risk &ctors using Coxproportional hrds regression models. The rsk ratios (RR) from the regression model is calculated
as follows:
RR=exp ( xexposure) (1)
The R. :for total moryin the ACS;cohort is 1.17, andthe differene ben high anIlw polluted areas is: 24.5 sg1n3.
Substituting in Equation l andsolvingfor the regression coeficient I gives a value of0.0064 for ,8 in theACS cohort..
Both the Six Cities andACS cohort studies evaluated individual-level risk for a 25 pac-year smoker (based on 20 cigarettes/day for
25 years in the ACS study). A pack per day sm ker smoking low-tar .cigarettes (0.5 mgtar) is expoed to adailyannual average ofabout
556, pg/i3 (0.5 mg/cigarette x 20 cigarettes/day 18 m3 air breahed/day). Subsuting p =0.0064 and exposure=556 p/3 in equa-
tion 1 aRR of 35.1, gPM25
ci tyvs. leat
poute ct) ad se to that power. hat is, ffor 1.17. Eposure
is how many times higher exposure a pack/day smoker of lotar cigaretes resident of polluted areas compared to low
polluted areas in theACS cohort. RRforsmokerbased ongroup-level RR = 1.7227 = 35.3 (slight dices are due to rounding differ-
ences in the calculation).
TableA- summarizes the group-level eoses of high versulow pollutcifor Six Cie ACS cohorts as well as individ-
e xposure forrpack/day smokers ofl RR vc u r t or urrents
ers fom gro lan individual-leveld from CS ohort
Clearly, the ecological based risks derived from group-levl eposures are: orders of magitude higher than te ri eate derive
f individual-level exposures. The smallest difference is wen te individual-leve risk is 2.07, compared to a of 35.3 based on
group-level data. For the average of a cigarette, he is 2.07 versus 32 1045. It is not
air pollution is that much mrore toxic thancr smoke.
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a per micrmeter b i.e
otsmoking :W be u t
Asamle cacuaion K for>: AOD is as folows _____ of -ki.J11 be ~ ~ ~ ~ ~ ~ ~ ~ TaleA-I Idii
.RR.=exp(j3x epsr)esiaeoPM5n *G:roup-level RR.ofAQoD.(an ch......... r..onic brncits asoiat.........:~--:
ed wit annual aerageo 70 jig/rn :.1.62.........;
= I.n 1.6/70 g 0.0689`. Variable
Exposure ofa-smoker: 20 cigarettes/day (low-tarcigarette) O'
Exposure .ofax-smwoker: 20 cigaretts/a (15 ng ta ciga Abrvst.s.. rid
rae = 16,66 pg/r3. .am.td of :..m.;.t:t:
Risk ofAOD .l)foir.ea-smokerderive.d from.... group-levl.PMj0 ¶Q%.... etA
..risk estimate :: :: :: phsi.historfwi.
Low.-tar ciarnette= ep (J X eposure) = ep (0.0689 X titn
556) =46.1:.. .. .. . ..; "Ooup-Ive*IPM,0R..
Aver.ag e cigarette . ep (0.00689 x 16,666) 7 x .iW.
.The comparison for the two symptomcategories aresummarized inTabl.eA2-1.
tn~ ~ ~ .
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